Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
Cole Maguire,Jing Chen,Nadine Rouphael,Harry Pickering,Hoang Van Phan,Abigail Glascock,Victoria Chu,Ravi Dandekar,David Corry,Farrah Kheradmand,Lindsey R. Baden,Rafick Selaky,Grace A. McComsey,Elias K. Haddad,Charles B. Cairns,Bali Pulendran,Ana Fernandez- Sesma,Viviana Simon,Jordan P. Metcalf,Nelson I Agudelo Higuita,William B. Messer,Mark M. David,Kari C. Nadeau,Monica Kraft,Chris Bime,Joanna Schaenman,David Erle,Carolyn S. Calfee,Mark A. Atkinson,Scott C. Brackenridge,Lauren I. R. Ehrlich,Ruth R. Montgomery,Albert C. Shaw,Catherine L. Hough,Linda N Geng,David A. Hafler,Alison D. Augustine,Patrice M. Becker,Bjoern Peters,Al Ozonoff,Seunghee Hee Kim-Schulze,Florian Krammer,Steve Bosinger,Walter Eckalbar,Matthew C. Altman,Michael Wilson,Leying Guan,Steven H. Kleinstein,IMPACC Network,Kinga K. Smolen,Elaine F. Reed,Ofer Levy,Holden Maecker,Peter Hunt,Hanno Steen,Joann Diray-Arce,Charles R. Langelier,Esther Melamed
DOI: https://doi.org/10.1101/2024.11.14.622799
2024-11-16
Abstract:Chronic viral infections are ubiquitous in humans, with individuals harboring multiple latent viruses that can reactivate during acute illnesses. Recent studies have suggested that SARS- CoV-2 infection can lead to reactivation of latent viruses such as Epstein-Barr Virus (EBV) and cytomegalovirus (CMV), yet, the extent and impact of viral reactivation in COVID-19 and its effect on the host immune system remain incompletely understood. Here we present a comprehensive multi-omic analysis of viral reactivation of all known chronically infecting viruses in 1,154 hospitalized COVID-19 patients, from the Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) study, who were followed prospectively for twelve months. We reveal significant reactivation of , , and families during acute stage of COVID-19 (0-40 days post- hospitalization), each exhibiting distinct temporal dynamics. We also show that viral reactivation correlated with COVID-19 severity, demographic characteristics, and clinical outcomes, including mortality. Integration of cytokine profiling, cellular immunophenotyping, metabolomics, transcriptomics, and proteomics demonstrated virus-specific host responses, including elevated pro-inflammatory cytokines (e.g. IL-6, CXCL10, and TNF), increased activated CD4+ and CD8+ T-cells, and upregulation of cellular replication genes, independent of COVID-19 severity and SARS-CoV-2 viral load. Notably, persistent reactivation during convalescence (≥3 months post-hospitalization) was associated with Post-Acute Sequelae of COVID-19 (PASC) symptoms, particularly physical function and fatigue. Our findings highlight a remarkable prevalence and potential impact of chronic viral reactivation on host responses and clinical outcomes during acute COVID-19 and long term PASC sequelae. Our data provide novel immune, transcriptomic, and metabolomic biomarkers of viral reactivation that may inform novel approaches to prognosticate, prevent, or treat acute COVID- 19 and PASC.
Immunology